Dietrich John Pauls - President and CEO, Director at DiaMedica Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
DMAC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dietrich John Pauls since 11/5/2023

Holdings reported by Dietrich John Pauls for DiaMedica Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Voting Common Shares, no par value per share 68.6K $192K $2.80 Jun 1, 2024 Direct
Stock Option (right to buy) 300K Jun 1, 2024 Direct Common Shares

Transactions reported by Dietrich John Pauls for DiaMedica Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.